TEST BANK FOR PSYCHOPHARMACOLOGY: DRUGS,
THE BRAIN AND BEHAVIOR 4TH EDITION BY
MEYER,100% CORRECT ANSWERS, GRADED A+
ANSWER:qBq--BenzodiazepamqCNSqdepressantqwithqquickqonsetqofqrelaxationq-
qWhichqofqtheqfollowingqmedicationsqwouldqbeqanqappropriateqPRNqmedicationqforqanqindi
vidualsqwithqanxietyqsymptoms?q
qA.qBuspirone
qB.qAlprazolamq
qC.qFluoxetine
qD.qSertraline
ANSWER:qCqclientqisqexhibitingqsignsqofqextrapyramidalqsyndromeq(EPS)q-
qAqclientqwhoqtakesqhaloperidolqbeginsqtoqshowqtremorsqandqaqshufflingqgait.qWhichqofqthe
qfollowingqPRNqmedicationsqshouldqtheqnurseqchoseqtoqadministerqforqtheseqsymptoms?q
qA.qChlorpromazine
qB.qDiazepamq
qC.qBenztropine
qD.qAmoxapine
ANSWER:qDqAlphaqAgonistq(stimulatesqreceptor)q-
qAqchildqisqtakingqguanfacineqforqADHD.qWhichqofqtheqfollowingqwouldqbeqpartqofqtheqclient
qeducationqassociatedqwithqadministrationqofqthisqmedication?q
qA.qDoqnotqtakeqwithqfoodsqthatqcontainqtyramine
qB.qAlwaysquseqsunblockqwhenqoutdoorsq
qC.qReportqforqbloodqtestsqonceqaqmonthq
qD.qDoqnotqdiscontinueqmedicationqabruptly
ANS:qCqAtypicalqantipsychoticsqproduceqlessqD2blockade;qthusqmovementqdisordersqareq
lessqofqaqproblem.qNoqevidenceqsuggestsqthatqtheqmedicationqremainsqinqtheqsystemqlong
erqnorqthatqitqactsqmoreqquicklyqtoqreduceqdelusions.qTheqatypicalsqareqnotqriskqfreeqforqN
MSq-
q1.qTheqnurseqmanagerqonqtheqpsychiatricqunitqwasqexplainingqtoqtheqnewqstaffqtheqdiffere
ncesqbetweenqtypicalqandqatypicalqantipsychotics.qTheqnurseqcorrectlyqstatesqthatqatypica
lqantipsychotics:
A.qRemainqinqtheqsystemqlonger
B.qActqmoreqquicklyqtoqreduceqdelusions
C.qProduceqfewerqextrapyramidalqeffects
D.qAreqriskqfreeqforqneurolepticqmalignantqsyndromeq(NMS)
, ANS:qCqIncreasedqtemperatureqisqtheqcardinalqsignqofqNMS.qThisqBPqisqnotqaqsignificantqf
eatureqofqNMS.qThereqareqnoqsignificantqfindingsqtoqsupportqtheqoptionsqrelatedqtoqrespira
tionsqorqpulseqrate.q-
q2.qTheqnurseqwouldqassessqforqneurolepticqmalignantqsyndromeq(NMS)qifqaqpatientqonqha
loperidolq(Haldol)qdevelopsqa:
A.q30qmmqHgqdecreaseqinqbloodqpressureqreading
B.qRespiratoryqrateqofq24qrespirationsqperqminute
C.qTemperatureqreadingqofq104°qF
D.qPulseqrateqofq70qbeatsqperqminute
ANS:qCqFluphenazineqadministrationqproducesqblockadeqofqcholinergicqreceptorsqgivingqr
iseqtoqanticholinergicqeffects,qsuchqasqdryqmouth,qblurredqvision,qandqconstipation.q-
q3.qAqpatientqtakingqfluphenazineq(Prolixin)qcomplainsqofqdryqmouthqandqblurredqvision.qW
hatqwouldqtheqnurseqassessqasqtheqlikelyqcauseqofqtheseqsymptoms?
A.qDecreasedqdopamineqatqreceptorqsites
B.qBlockadeqofqhistamine
C.qCholinergicqblockade
D.qAdrenergicqblocking
ANS:qA
TDqmanifestsqasqabnormalqmovementsqofqvoluntaryqmuscleqgroupsqafterqaqprolongedqper
iodqofqdopamine
blockade.qMovementsqmayqaffectqanyqmuscleqgroup,qbutqmusclesqofqtheqface,qmouth,qton
gue,qandqdigitsqare
commonlyqaffected.qFallingqasleepqisqreflectiveqofqtheqsedativeqeffectqofqtheseqmedication
s.qMuscleqrigidityqandqdroolingqreflectqEPSqcausedqfromqimbalanceqbetweenqdopamineqa
ndqacetylcholine.q-
q4.qWhichqbehaviorqdisplayedqbyqaqpatientqreceivingqaqtypicalqantipsychoticqmedicationqw
ouldqbeqassessedqasqdisplayingqbehaviorsqcharacteristicqofqtardiveqdyskinesiaq(TD)?
A.qGrimacingqandqlipqsmacking
B.qFallingqasleepqinqtheqchairqandqrefusingqtoqeatqlunch
C.qExperiencingqmuscleqrigidityqandqtremors
D.qHavingqexcessiveqsalivationqandqdrooling
ANS:qA
IncreasedqlevelsqofqGABAqreduceqanxiety,qthusqanyqpotentiationqofqGABAqactionqshouldqr
esultqinqanxiety
reduction.qMemoryqenhancementqisqassociatedqwithqacetylcholineqandqsubstanceqP.qTho
ughtqdisorganizationqisqassociatedqwithqdopamine.qGABAqisqnotqassociatedqwithqsensoryq
perceptualqalterations.q-
q5.qAqnurseqadministersqaqmedicationqthatqpotentiatesqtheqactionqofqGABA.qWhichqfindingq
wouldqbeqexpected?
THE BRAIN AND BEHAVIOR 4TH EDITION BY
MEYER,100% CORRECT ANSWERS, GRADED A+
ANSWER:qBq--BenzodiazepamqCNSqdepressantqwithqquickqonsetqofqrelaxationq-
qWhichqofqtheqfollowingqmedicationsqwouldqbeqanqappropriateqPRNqmedicationqforqanqindi
vidualsqwithqanxietyqsymptoms?q
qA.qBuspirone
qB.qAlprazolamq
qC.qFluoxetine
qD.qSertraline
ANSWER:qCqclientqisqexhibitingqsignsqofqextrapyramidalqsyndromeq(EPS)q-
qAqclientqwhoqtakesqhaloperidolqbeginsqtoqshowqtremorsqandqaqshufflingqgait.qWhichqofqthe
qfollowingqPRNqmedicationsqshouldqtheqnurseqchoseqtoqadministerqforqtheseqsymptoms?q
qA.qChlorpromazine
qB.qDiazepamq
qC.qBenztropine
qD.qAmoxapine
ANSWER:qDqAlphaqAgonistq(stimulatesqreceptor)q-
qAqchildqisqtakingqguanfacineqforqADHD.qWhichqofqtheqfollowingqwouldqbeqpartqofqtheqclient
qeducationqassociatedqwithqadministrationqofqthisqmedication?q
qA.qDoqnotqtakeqwithqfoodsqthatqcontainqtyramine
qB.qAlwaysquseqsunblockqwhenqoutdoorsq
qC.qReportqforqbloodqtestsqonceqaqmonthq
qD.qDoqnotqdiscontinueqmedicationqabruptly
ANS:qCqAtypicalqantipsychoticsqproduceqlessqD2blockade;qthusqmovementqdisordersqareq
lessqofqaqproblem.qNoqevidenceqsuggestsqthatqtheqmedicationqremainsqinqtheqsystemqlong
erqnorqthatqitqactsqmoreqquicklyqtoqreduceqdelusions.qTheqatypicalsqareqnotqriskqfreeqforqN
MSq-
q1.qTheqnurseqmanagerqonqtheqpsychiatricqunitqwasqexplainingqtoqtheqnewqstaffqtheqdiffere
ncesqbetweenqtypicalqandqatypicalqantipsychotics.qTheqnurseqcorrectlyqstatesqthatqatypica
lqantipsychotics:
A.qRemainqinqtheqsystemqlonger
B.qActqmoreqquicklyqtoqreduceqdelusions
C.qProduceqfewerqextrapyramidalqeffects
D.qAreqriskqfreeqforqneurolepticqmalignantqsyndromeq(NMS)
, ANS:qCqIncreasedqtemperatureqisqtheqcardinalqsignqofqNMS.qThisqBPqisqnotqaqsignificantqf
eatureqofqNMS.qThereqareqnoqsignificantqfindingsqtoqsupportqtheqoptionsqrelatedqtoqrespira
tionsqorqpulseqrate.q-
q2.qTheqnurseqwouldqassessqforqneurolepticqmalignantqsyndromeq(NMS)qifqaqpatientqonqha
loperidolq(Haldol)qdevelopsqa:
A.q30qmmqHgqdecreaseqinqbloodqpressureqreading
B.qRespiratoryqrateqofq24qrespirationsqperqminute
C.qTemperatureqreadingqofq104°qF
D.qPulseqrateqofq70qbeatsqperqminute
ANS:qCqFluphenazineqadministrationqproducesqblockadeqofqcholinergicqreceptorsqgivingqr
iseqtoqanticholinergicqeffects,qsuchqasqdryqmouth,qblurredqvision,qandqconstipation.q-
q3.qAqpatientqtakingqfluphenazineq(Prolixin)qcomplainsqofqdryqmouthqandqblurredqvision.qW
hatqwouldqtheqnurseqassessqasqtheqlikelyqcauseqofqtheseqsymptoms?
A.qDecreasedqdopamineqatqreceptorqsites
B.qBlockadeqofqhistamine
C.qCholinergicqblockade
D.qAdrenergicqblocking
ANS:qA
TDqmanifestsqasqabnormalqmovementsqofqvoluntaryqmuscleqgroupsqafterqaqprolongedqper
iodqofqdopamine
blockade.qMovementsqmayqaffectqanyqmuscleqgroup,qbutqmusclesqofqtheqface,qmouth,qton
gue,qandqdigitsqare
commonlyqaffected.qFallingqasleepqisqreflectiveqofqtheqsedativeqeffectqofqtheseqmedication
s.qMuscleqrigidityqandqdroolingqreflectqEPSqcausedqfromqimbalanceqbetweenqdopamineqa
ndqacetylcholine.q-
q4.qWhichqbehaviorqdisplayedqbyqaqpatientqreceivingqaqtypicalqantipsychoticqmedicationqw
ouldqbeqassessedqasqdisplayingqbehaviorsqcharacteristicqofqtardiveqdyskinesiaq(TD)?
A.qGrimacingqandqlipqsmacking
B.qFallingqasleepqinqtheqchairqandqrefusingqtoqeatqlunch
C.qExperiencingqmuscleqrigidityqandqtremors
D.qHavingqexcessiveqsalivationqandqdrooling
ANS:qA
IncreasedqlevelsqofqGABAqreduceqanxiety,qthusqanyqpotentiationqofqGABAqactionqshouldqr
esultqinqanxiety
reduction.qMemoryqenhancementqisqassociatedqwithqacetylcholineqandqsubstanceqP.qTho
ughtqdisorganizationqisqassociatedqwithqdopamine.qGABAqisqnotqassociatedqwithqsensoryq
perceptualqalterations.q-
q5.qAqnurseqadministersqaqmedicationqthatqpotentiatesqtheqactionqofqGABA.qWhichqfindingq
wouldqbeqexpected?
